TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-17

Archived explainer. For the current picture see today's SLS page.

Why Is SELLAS LIFE SCIENCES (SLS) Stock Up Today?

By the Top Tier Newswire AI Desk · November 17, 2026 at 11:54 AM ET · reviewed against 17 wire stories

SELLAS LIFE SCIENCES (SLS) is up +164.66% in the latest session. Our newswire has captured 17 stories on SLS across 9 sources in the last 36 hours, with AI sentiment reading bullish (avg 68/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Sellas Life Sciences (SLS) shares surged 164.66% to $19.77 on Tuesday. The primary driver was the publication of positive topline results from the company’s pivotal Phase 3 REGAL trial. The data indicated that the GPS cancer vaccine met its overall-survival endpoint in leukemia.

What Happened

The stock opened at $28.50, representing a gap of 281.5% from the prior close of $7.47. Trading was briefly halted due to a volatility pause before resuming. The company reported that its experimental vaccine extended survival in the pivotal leukemia trial. This late-stage clinical win triggered a sharp revaluation of the firm’s market position.

What The Data Shows

Intraday activity showed the stock reaching a session high of $34.19 at 8:30 AM ET before settling to a low of $16.70 at 9:55 AM ET. The final price stood at $19.54. Volume reached 72.4 million shares, which is 10.7 times the three-month daily average. The company has a market cap of $1.6 billion and remains unprofitable with a trailing twelve-month EPS of -0.20. Its beta is 2.70, and the 52-week range spans $1.39 to $15.88. Over the last eight sessions, the stock had moved down 5.2% from $7.88 to $7.47. Unusual options activity included 11 notable prints, with call premium at $3.6 million and put premium at $16.2 million. The largest single print was $3.8 million. Retail traders on Reddit and X are discussing the move, with some noting the significant gain relative to the previous market cap.

What To Watch

The company recently reported its third-quarter 2026 financial results and corporate update. Investors will monitor how the stock stabilizes after the initial volatility and whether the positive trial results lead to further institutional interest or additional clinical milestones.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

SLS by the numbers

Last: $19.77Session: +164.66%7 sessions: +127.43%Coverage: 17 stories / 9 sourcesAI sentiment: 68/100 (bullish)Mkt cap: $1.6B52w: $1.39 to $15.88
SLS · Nov 17 session (5-min) · +129.31% vs prior close · updated 8:46 PM ET
$6.06$19.25$32.43prev close $7.47$17.138:30 AM11:21 AM2:12 PM5:03 PM7:55 PM8:30 AM · $31.028:35 AM · $27.848:40 AM · $25.258:45 AM · $25.108:50 AM · $23.688:55 AM · $25.059:00 AM · $27.019:05 AM · $27.099:10 AM · $27.109:15 AM · $26.069:20 AM · $26.409:25 AM · $24.009:30 AM · $21.449:35 AM · $20.689:45 AM · $17.839:50 AM · $17.839:55 AM · $17.7910:00 AM · $19.7310:05 AM · $20.4910:10 AM · $19.2410:15 AM · $19.5510:20 AM · $19.3910:25 AM · $19.3310:30 AM · $19.7010:35 AM · $20.2310:40 AM · $20.2710:45 AM · $20.9210:50 AM · $20.2510:55 AM · $20.0711:00 AM · $20.2511:05 AM · $20.5511:10 AM · $20.7511:15 AM · $20.8211:20 AM · $21.3211:25 AM · $20.3311:30 AM · $20.7611:35 AM · $20.4811:40 AM · $20.1611:45 AM · $19.6111:50 AM · $19.6611:55 AM · $19.5512:00 PM · $20.1312:05 PM · $20.4812:10 PM · $20.4612:15 PM · $20.3212:20 PM · $20.3612:25 PM · $20.2512:30 PM · $20.1612:35 PM · $20.1512:40 PM · $20.1712:45 PM · $20.2512:50 PM · $19.8812:55 PM · $19.691:00 PM · $19.831:05 PM · $19.821:10 PM · $19.391:15 PM · $18.771:20 PM · $18.971:25 PM · $19.651:30 PM · $19.231:35 PM · $19.331:40 PM · $19.341:45 PM · $19.641:50 PM · $19.771:55 PM · $19.802:00 PM · $19.662:05 PM · $19.832:10 PM · $19.732:15 PM · $19.662:20 PM · $19.522:25 PM · $19.682:30 PM · $19.652:35 PM · $19.662:40 PM · $19.292:45 PM · $19.362:50 PM · $19.342:55 PM · $19.323:00 PM · $19.223:05 PM · $19.533:10 PM · $19.323:15 PM · $19.273:20 PM · $19.313:25 PM · $19.143:30 PM · $18.903:35 PM · $19.053:40 PM · $19.023:45 PM · $19.033:50 PM · $18.993:55 PM · $19.184:00 PM · $18.174:05 PM · $16.954:10 PM · $16.404:15 PM · $15.904:20 PM · $16.104:25 PM · $15.904:30 PM · $16.004:35 PM · $17.104:40 PM · $16.974:45 PM · $17.104:50 PM · $17.304:55 PM · $17.135:00 PM · $16.955:05 PM · $16.865:10 PM · $16.855:15 PM · $16.805:20 PM · $16.855:25 PM · $16.505:30 PM · $16.615:35 PM · $16.905:40 PM · $16.915:45 PM · $17.105:50 PM · $16.995:55 PM · $16.956:00 PM · $16.896:05 PM · $16.896:10 PM · $16.866:15 PM · $16.996:20 PM · $16.986:25 PM · $16.816:30 PM · $16.896:35 PM · $16.896:40 PM · $16.916:45 PM · $16.896:50 PM · $16.946:55 PM · $16.907:00 PM · $16.947:05 PM · $16.997:10 PM · $17.017:15 PM · $17.127:20 PM · $17.207:25 PM · $16.997:30 PM · $17.097:35 PM · $17.097:40 PM · $17.167:45 PM · $17.177:50 PM · $17.087:55 PM · $17.13
AI sentiment, last 36h · averaged over 17 stories · 68/100 bullish
AI sentiment 68/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishSeeking Alpha · sentiment 78 · SELLAS surges on late-stage trial win for cancer vaccineSeeking Alpha · 78SELLAS surges on late-stage trial win for cancer vaccineTipRanks · sentiment 82 · Sellas Life Sciences Stock Sls Rockets 236 On Stellar Phase 3 Trial ResultsTipRanks · 82Sellas Life Sciences Stock Sls Rockets 236 On Stellar Phase 3 Trial ResultsThe Fly · sentiment 78 · Why Sellas Life Sciences Stock Is Skyrocketing Over 200 Today And What This Analyst Sees NextThe Fly · 78Why Sellas Life Sciences Stock Is Skyrocketing Over 200 Today And What This Analyst Sees …Investing.com Markets · sentiment 64 · Why is Sellas Life Sciences stock surging today?Investing.com Markets · 64Why is Sellas Life Sciences stock surging today?Fidelity News · sentiment 58 · Sector Update: Healthcare Stocks Lean Lower Pre-Bell TuesdayFidelity News · 58Sector Update: Healthcare Stocks Lean Lower Pre-Bell TuesdayThe Fly · sentiment 42 · Sellas Life Sciences trading halted, volatility trading pauseThe Fly · 42Sellas Life Sciences trading halted, volatility trading pauseThe Fly · sentiment 50 · Sellas Life Sciences trading resumesThe Fly · 50Sellas Life Sciences trading resumesGuruFocus · sentiment 85 · SELLAS Life Sciences (SLS) Surges 200% Premarket on Positive Phase 3 REGAL Trial ResultsGuruFocus · 85SELLAS Life Sciences (SLS) Surges 200% Premarket on Positive Phase 3 REGAL Trial Results
3d agoGuruFocusBULLISH 85Product/PR

SELLAS Life Sciences (SLS) Surges 200% Premarket on Positive Phase 3 REGAL Trial Results

3d agoThe FlyNEUTRAL 50General

Sellas Life Sciences trading resumes

3d agoThe FlyBEARISH 42General

Sellas Life Sciences trading halted, volatility trading pause

3d agoFidelity NewsBULLISH 58Earnings

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Tuesday

Healthcare stocks were leaning lower pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV.NaE) declining by 1% and the Vanguard Health Care Index Fund ETF Shares down 0.4%. Sellas Life Sciences (SLS.NaE) stock surged past 269% after the company said its experimental cancer vaccine, galinpepimut-S, met the main goal in a phase 3 trial involving patients with acute myeloid leukemia.

3d agoInvesting.com MarketsBULLISH 64General

Why is Sellas Life Sciences stock surging today?

Why is Sellas Life Sciences stock surging today?

3d agoThe FlyBULLISH 78General

Why Sellas Life Sciences Stock Is Skyrocketing Over 200 Today And What This Analyst Sees Next

3d agoTipRanksBULLISH 82Product/PR

Sellas Life Sciences Stock Sls Rockets 236 On Stellar Phase 3 Trial Results

SELLAS Life Sciences stock rocketed higher on Tuesday after the company published results from a clinical trial.

3d agoSeeking AlphaBULLISH 78Product/PR

SELLAS surges on late-stage trial win for cancer vaccine

SELLAS Life Sciences (SLS) stock jumps as the company says its GPS cancer vaccine met its Phase 3 REGAL trial’s overall-survival endpoint in leukemia. Read more here.

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on SLS: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier SLS move explainers: 2026-11-20 · 2026-11-19 · 2026-11-18 · 2026-11-17 · 2026-11-13 · 2026-10-28 · 2026-10-20 · 2026-10-19 · 2026-08-31 · 2026-08-28 · 2026-08-27 · 2026-08-25 · 2026-08-24 · 2026-08-21 · 2026-08-17